ProcuraAxisBeta
Sign inCreate Free Account
Home / Opportunities / Opportunity
PROCUREMENT OPPORTUNITY

NHS National Framework for Etravirine 200mg tablets, Raltegravir 400mg tablets, Ritonavir 100mg tablets

NHS England · Contract details notice on Find a Tender

Tender information last checkedLast checked 24 Sept 2026, 13:21.

Opportunity overview

Project title: NHS National Framework for Etravirine 200mg tablets, Raltegravir 400mg tablets, Ritonavir 100mg tablets Offer reference number: CM/TNS/26/5745 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months. CM/TNS/26/5745 Etravirine 200mg tablets, Raltegravir 400mg tablets, Ritonavir 100mg Lot 1 DNE, LNW & SOFE 1 November 2026 to 31 October 2027 (12 months) Lot 2 DNW & MAE 1 November 2026 to 31 October 2027 (12 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Awarded to

Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.

Lupin Healthcare (UK) Limited

Matched by number
Shared contract value
£8.5m
Awarded
Not supplied
Contract signed
11 Aug 2026
Including VAT
£10.3m
Suppliers
One of 4 awarded suppliers
Award ID
1
Status
active
Identifier
GB-COH 06925119
Location
Slough, UKJ11, SL1 2BE, United Kingdom

Merck Sharpe & Dohme (UK) Limited

Matched by number
Shared contract value
£8.5m
Awarded
Not supplied
Contract signed
11 Aug 2026
Including VAT
£10.3m
Suppliers
One of 4 awarded suppliers
Award ID
1
Status
active
Identifier
GB-COH 00233687
Location
London, UKI31, EC2M 6UR, United Kingdom

Orifarm UK

Matched by number
Shared contract value
£8.5m
Awarded
Not supplied
Contract signed
11 Aug 2026
Including VAT
£10.3m
Suppliers
One of 4 awarded suppliers
Award ID
1
Status
active
Identifier
GB-COH 10015046
Location
Hemel Hempstead, UKH23, HP2 4TZ, United Kingdom

Unicorn Pharmaceuticals Ltd

Matched by number
Shared contract value
£8.5m
Awarded
Not supplied
Contract signed
11 Aug 2026
Including VAT
£10.3m
Suppliers
One of 4 awarded suppliers
Award ID
1
Status
active
Identifier
GB-COH 14867894
Location
Stanmore, UKI74, HA7 1JS, United Kingdom

Classification

No classification was supplied.

Lots

  • Lot 1Value not stated

Documents and notices

Published notice details

Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.

Scope, procedure and submissions

Id
CM/TNS/26/5745
Status
complete
Procurement Method
open
Procurement Method Details
Open procedure

Legal basis

Id
2023/54
Scheme
UKPGA

Covered By

GPA

Techniques

Has Framework Agreement
Yes

Framework Agreement

Method
withReopeningCompetition
Type
open
Buyer Categories
Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points
Description
Please refer to the ITO Documents for the Operation Description

Lots and requirements

Entry 1
Id
1
Status
complete

Published documents

Entry 1
Id
conflictOfInterest
Document Type
conflictOfInterest
Description
Not published

Buyer, suppliers and contacts

Organisation 1
Name
NHS England
Id
GB-PPON-PDPT-3135-BWWY

Identifier

Scheme
GB-PPON
Id
PDPT-3135-BWWY

Address

Street Address
Wellington House, 133-135 Waterloo Rd
Locality
London
Postal Code
SE1 8UG
Country
GB
Country Name
United Kingdom
Region
UKI45

Contact

Roles

buyer

Details

Classifications

Entry 1
Scheme
UK_CA_TYPE
Id
publicAuthorityCentralGovernment
Description
Public authority - central government
Organisation 2
Name
Merck Sharpe & Dohme (UK) Limited
Id
GB-COH-00233687

Identifier

Scheme
GB-COH
Id
00233687

Address

Street Address
120 Moorgate
Locality
London
Postal Code
EC2M 6UR
Country
GB
Country Name
United Kingdom
Region
UKI31

Contact

Roles

supplier

Details

Scale
large
Vcse
No
Public Service Mission Organization
No
Sheltered Workshop
No
Organisation 3
Name
Orifarm UK
Id
GB-COH-10015046

Identifier

Scheme
GB-COH
Id
10015046

Address

Street Address
Ground Floor, Suite A2 Breakspear Way
Locality
Hemel Hempstead
Postal Code
HP2 4TZ
Country
GB
Country Name
United Kingdom
Region
UKH23

Contact

Roles

supplier

Details

Scale
sme
Vcse
No
Public Service Mission Organization
No
Sheltered Workshop
No
Organisation 4
Name
Unicorn Pharmaceuticals Ltd
Id
GB-COH-14867894

Identifier

Scheme
GB-COH
Id
14867894

Address

Street Address
Devonshire House 582 Honeypot Lane
Locality
Stanmore
Postal Code
HA7 1JS
Country
GB
Country Name
United Kingdom
Region
UKI74

Contact

Roles

supplier

Details

Scale
sme
Vcse
No
Public Service Mission Organization
No
Sheltered Workshop
No
Organisation 5
Name
Lupin Healthcare (UK) Limited
Id
GB-COH-06925119

Identifier

Scheme
GB-COH
Id
06925119

Address

Street Address
The Urban Building 3-9 Albert Street
Locality
Slough
Postal Code
SL1 2BE
Country
GB
Country Name
United Kingdom
Region
UKJ11

Contact

Roles

supplier

Details

Scale
sme
Vcse
No
Public Service Mission Organization
No
Sheltered Workshop
No

Award information

Award 1
Id
1
Status
active
Main Procurement Category
goods

Items

Item 1
Id
1
Related Lot
1

Additional Classifications

Entry 1
Scheme
CPV
Id
33600000
Description
Pharmaceutical products

Delivery locations

Entry 1
Region
UKC
Country
GB
Country Name
United Kingdom
Entry 2
Region
UKD
Country
GB
Country Name
United Kingdom
Entry 3
Region
UKF
Country
GB
Country Name
United Kingdom
Entry 4
Region
UKG
Country
GB
Country Name
United Kingdom
Entry 5
Region
UKH
Country
GB
Country Name
United Kingdom
Entry 6
Region
UKJ
Country
GB
Country Name
United Kingdom
Entry 7
Region
UKK
Country
GB
Country Name
United Kingdom

Suppliers

Supplier 1
Id
GB-COH-00233687
Name
Merck Sharpe & Dohme (UK) Limited
Supplier 2
Id
GB-COH-10015046
Name
Orifarm UK
Supplier 3
Id
GB-COH-14867894
Name
Unicorn Pharmaceuticals Ltd
Supplier 4
Id
GB-COH-06925119
Name
Lupin Healthcare (UK) Limited

Related lots

1

Contracts and changes

Entry 1
Id
1
Award ID
1
Title
NHS National Framework for Etravirine 200mg tablets, Raltegravir 400mg tablets, Ritonavir 100mg tablets
Status
active
Has Renewal
Yes
Above Threshold
Yes
Date Signed
12 Aug 2026, 00:00

Period

Starts
1 Nov 2026, 00:00
Ends
31 Oct 2027, 23:59
Max Extent Date
31 Oct 2029, 23:59

Renewal

Description
Option or options to extend (at the discretion of the Authority) up to a maximum of 24 months.

Value

Including VAT
10,254,000
Amount
8,545,000
Currency
GBP

Documents

Entry 1
Id
A-21127
Document Type
contractSigned
Description
UK7 CONTRACT COPY CM-TNS-26-5745 Etravirine Raltegravir Ritonavir
Format
application/pdf
Entry 2
Id
083119-2026
Document Type
contractNotice
Notice Type
UK7
Description
Contract details notice on Find a Tender
Published
2 Sept 2026, 14:59
Format
text/html

Recorded locations

  • Buyer location · London · UKI45 · SE1 8UG · United Kingdom

Notice and amendment history

5 published notice versions reviewed by ProcuraAxis.

5 VERSIONS
  1. 022494-2026Pipeline notice on Find a Tender ·
  2. 030757-2026Preliminary market engagement notice on Find a Tender ·
  3. 052395-2026Tender notice on Find a Tender ·
  4. 071842-2026Contract award notice on Find a Tender ·
  5. 083119-2026Contract details notice on Find a Tender ·